SCHEMBL5771554

SCHEMBL5771554

O=C(CCc1cnoc1-c1ccc(F)cc1)N1CCC(O)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2B Q13224 1/20 0.40
LMNA P02545 3/20 0.39
KDM4E B2RXH2 1/20 0.39
MAPT P10636 1/20 0.39
RAB9A P51151 1/20 0.39
KMT2A Q03164 3/20 0.39
CACNA1B Q00975 2/20 0.39
ALOX15 P16050 1/20 0.39
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.39
ALDH1A1 P00352 1/20 0.39
HPGD P15428 1/20 0.39
TRPV1 Q8NER1 1/20 0.39
ME2 P23368 1/20 0.38
ME1 P48163 1/20 0.38
ME3 Q16798 1/20 0.38
GFER P55789 1/20 0.37
C3AR1 Q16581 1/20 0.37
CCNC P24863 1/20 0.37
CDK8 P49336 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5773586 0.89 MAPT (0.43) LMNAMAPTRAB9AALDH1A1HPGD
SCHEMBL5799823 0.88 KMT2A (0.55) LMNAKDM4EMAPTRAB9AKMT2A
SCHEMBL5776036 0.87 LMNA (0.46) LMNAKDM4EMAPTRAB9AKMT2A
SCHEMBL5773468 0.87 LMNA (0.46) LMNAKDM4EMAPTRAB9AKMT2A
SCHEMBL5774738 0.87 LMNA (0.46) LMNAKDM4EMAPTRAB9AKMT2A
SCHEMBL5776181 0.87 KDM4E (0.38) LMNAKDM4EMAPTRAB9AKMT2A
SCHEMBL5773845 0.86 TNKS (0.40) GRIN2BLMNAMAPTALDH1A1HPGD
SCHEMBL5774326 0.85 GABRA5 (0.39) LMNAMAPTRAB9AKMT2AALDH1A1
SCHEMBL5771838 0.85 KDM4E (0.53) LMNAKDM4EMAPTKMT2AALOX15
SCHEMBL5771819 0.84 RAB9A (0.42) GRIN2BLMNAKDM4EMAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060084690-A1 Isoxazole derivatives MOMOSE YU 2006-04-20 US disclosed
US-7022725-B2 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-04-04 US disclosed
US-20040048908-A1 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-03-11 US disclosed
EP-1340749-A1 ISOXAZOLE DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-09-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060084690-A1 Isoxazole derivatives INSR, GPR119, INSRR GRIN2B 2007/4885LMNA 2770/4885KDM4E 3953/4885
US-20040048908-A1 Isoxazole derivatives GPR119, INSR, IRS1 GRIN2B 2374/4885LMNA 2605/4885KDM4E 3347/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.